דטסקאן

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

现在购买

有效成分:

IOFLUPANE

可用日期:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

ATC代码:

V09AB03

药物剂型:

תמיסה להזרקה

组成:

IOFLUPANE 74 MBQ/ML

给药途径:

תוך-ורידי

处方类型:

מרשם נדרש

厂商:

GE HEALTHCARE B.V., THE NETHERLAND

治疗组:

OTHER DOPAMINERGIC AGENTS

治疗领域:

IODINE IOFLUPANE (123I)

疗效迹象:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

授权日期:

2014-11-30

其他语言的文件

资料单张 资料单张 英文 17-08-2016
产品特点 产品特点 英文 16-12-2021
公众评估报告 公众评估报告 英文 16-12-2021

搜索与此产品相关的警报

查看文件历史